Antihypertensive drug use during pregnancy in Japan

Hypertens Res. 2023 Feb;46(2):548-549. doi: 10.1038/s41440-022-01101-0. Epub 2022 Dec 2.

Authors

Taku Obara^{1

2

3}, Mami Ishikuro^{4

5}, Fumihiko Ueno^{4

5}, Aoi Noda^{4

5

6}, Keiko Murakami^{4

5}, Shinichi Kuriyama^{4

5

7}

Affiliations

¹ Department of Preventive Medicine and Epidemiology, Tohoku University Tohoku Medical Megabank Organization, Sendai, Japan. obara-t@hosp.tohoku.ac.jp.
² Division of Molecular Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Japan. obara-t@hosp.tohoku.ac.jp.
³ Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan. obara-t@hosp.tohoku.ac.jp.
⁴ Department of Preventive Medicine and Epidemiology, Tohoku University Tohoku Medical Megabank Organization, Sendai, Japan.
⁵ Division of Molecular Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Japan.
⁶ Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan.
⁷ International Research Institute of Disaster Science, Sendai, Japan.

PMID: 36460830
DOI: 10.1038/s41440-022-01101-0

No abstract available

Publication types

Letter
Comment

MeSH terms

Antihypertensive Agents* / adverse effects
Female
Humans
Hypertension* / drug therapy
Japan
Pregnancy

Substances

Antihypertensive Agents